This webinar will address how AIA proceedings impact Life Sciences patents. A review of PTAB statistics pertaining to Life Sciences patents will be provided and compared against other industries. The panel will discuss the impact of AIA proceedings on parallel Hatch Waxman litigation and BPCIA litigation. Speakers will also discuss the advantages and disadvantages of AIA proceedings, and debate ways that the proceedings could be improved to address industry concerns.

Our panel of distinguished inhouse counsel, Larry Coury, Stephanie Donahue, Henry Hadad, and Stuart Watt, moderated by experienced trial counsel, Paul Berghoff, will guide us through the issues and arguments concerning the current state of enablement and written description law and where the law may be headed.

Join speakers from IPO’s Anticounterfeiting & Antipiracy and AI & New Emerging Technologies Committees to hear about developments related to AI and Effective Enforcement. In addition to demystifying the technology, the panel will discuss how AI and machine learning has revolutionized IP enforcement in the online environment—for example through platforms incorporating AI that assist in identifying online sales of counterfeit products. The panel will also provide brand owner, patent practitioner, and legislative perspectives on AI & machine learning.

This program covers the common ethics issues that IP attorneys confront on a regular basis. Topics include: • New rules and key opinions • Confidentiality and privilege in IP cases, including issues arising from protective order violations • Duty of loyalty and conflict issues • Duties related to candor to the USPTO and courts • Duties regarding third parties • USPTO OED rule changes and disciplinary decisions